| http://www.w3.org/ns/prov#value | - It is preferred in this connection for the monoparamunity inducers of the invention to include combinations of one or more myxomavirus strainsor their paramunizing viral components.The paramunizing properties induced in a mammal such as, for example, in humans through administration of myxomavirus monoparamunity inducer are particularly beneficial for eliminating dysfunctions, for increasing the n
|
